High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$612K
$612,983
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
EBS
S
Emergent BioSolutions Inc.
Williams Paul Anthony
• Officer • SVP, Products Business
10b5-1 Sell
2026-04-01
$33,760
|
||||||
| EBS |
Emergent BioSolutions Inc.
|
Officer • SVP, Products Business
10b5-1 Sell
|
2026-04-01 | $33,760 | S | Form 4 |
|
EBS
S
Emergent BioSolutions Inc.
DeGolyer Donald W
• Director
10b5-1 SellΔOwn -12.9%
2025-11-10
$187,623
|
||||||
| EBS |
Emergent BioSolutions Inc.
|
Director
10b5-1 SellΔOwn -12.9%
|
2025-11-10 | $187,623 | S | Form 4 |
| EBS |
Emergent BioSolutions Inc.
|
Director
10b5-1 Sell
|
2025-11-07 | $85,520 | S | Form 4 |
|
EBS
S
Emergent BioSolutions Inc.
Glessner Coleen
• Officer • EVP, Quality & Ethics, and CPL
10b5-1 SellΔOwn -17.5%
2025-10-07
$306,080
|
||||||
| EBS |
Emergent BioSolutions Inc.
|
Officer • EVP, Quality & Ethics, and CPL
10b5-1 SellΔOwn -17.5%
|
2025-10-07 | $306,080 | S | Form 4 |